Pacira Pharmaceuticals CEO David Stack's 2018 pay jumps 24% to $5.8M
Pacira Pharmaceuticals reports 2018 executive compensation
By ExecPay News
Published: April 22, 2019
Pacira Pharmaceuticals reported fiscal year 2018 executive compensation information on April 22, 2019.
In 2018, five executives at Pacira Pharmaceuticals received on average a compensation package of $2.8M, a 27% increase compared to previous year.
Average pay of disclosed executives at Pacira Pharmaceuticals
David Stack, Chief Executive Officer, received $5.8M in total, which increased by 24% compared to 2017. 56% of Stack's compensation, or $3.2M, was in option awards. Stack also received $679K in bonus, $808K in salary, $1.1M in stock awards, as well as $16K in other compensation.
For fiscal year 2018, the median employee pay was $177,153 at Pacira Pharmaceuticals. Therefore, the ratio of David Stack's pay to the median employee pay was 33 to one.
Dennis McLoughlin, Chief Commercial Officer, received a compensation package of $2.5M. 67% of the compensation package, or $1.7M, was in option awards.
Richard Scranton, Chief Medical Officer, earned $2.3M in 2018, a 34% increase compared to previous year.
Kristen Williams, Chief Administrative Officer, received $1.9M in 2018, which increases by 27% compared to 2017.
Charles A. Reinhart, III, Chief Financial Officer, earned $1.4M in 2018, a 7% increase compared to previous year.
Related executives
David Stack
Pacira Pharmaceuticals
Chief Executive Officer
Charles Reinhart
Pacira Pharmaceuticals
Chief Financial Officer
Dennis McLoughlin
Pacira Pharmaceuticals
Chief Commercial Officer
Richard Scranton
Pacira Pharmaceuticals
Chief Medical Officer
Kristen Williams
Pacira Pharmaceuticals
Chief Administrative Officer
You may also like
Source: SEC filing on April 22, 2019.